SCHEMBL5518692

SCHEMBL5518692

CC(C)=CCc1c(O)ccc(C(=O)/C=C/c2ccc(Cl)cc2)c1O

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 3/20 0.82
DHODH Q02127 1/20 0.82
MAOB P27338 5/20 0.67
MEN1 O00255 2/20 0.67
LMNA P02545 2/20 0.67
MAPT P10636 2/20 0.67
KMT2A Q03164 2/20 0.67
ALDH1A1 P00352 1/20 0.67
GAA P10253 1/20 0.67
CYP19A1 P11511 2/20 0.63
TYR P14679 1/20 0.63
PTGS1 P23219 2/20 0.60
PTGS2 P35354 2/20 0.60
ABCB1 P08183 1/20 0.58
CASP3 P42574 1/20 0.56
SENP8 Q96LD8 1/20 0.56
SENP7 Q9BQF6 1/20 0.56
SENP6 Q9GZR1 1/20 0.56
MAOA P21397 2/20 0.52
GUSB P08236 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5518698 1.00 PTPN1 (0.82) PTPN1DHODHMAOBMEN1LMNA
SCHEMBL5515045 0.90 MAOB (0.84) PTPN1DHODHMAOBMEN1LMNA
SCHEMBL5515048 0.90 MAOB (0.84) PTPN1DHODHMAOBMEN1LMNA
SCHEMBL5515052 0.90 MAOB (0.84) PTPN1DHODHMAOBMEN1LMNA
Isobavachalcone SCHEMBL600137 0.90 PTPN1 (1.00) PTPN1DHODHMAOBMEN1LMNA
Isocordoin SCHEMBL24075559 0.88 PTPN1 (0.81) PTPN1DHODHMAOBMEN1LMNA
SCHEMBL29696899 0.86 PTPN1 (0.82) PTPN1DHODHMAOBMEN1LMNA
SCHEMBL14679208 0.86 PTPN1 (0.78) PTPN1DHODHMAOBMEN1LMNA
Kanzonol C SCHEMBL7185292 0.84 PTPN1 (1.00) PTPN1DHODHMAOBMEN1LMNA
Kanzonol C SCHEMBL7179065 0.84 PTPN1 (1.00) PTPN1DHODHMAOBMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070092551-A1 Therapeutic agent TAKARA BIO INC. (JP) 2007-04-26 US claimed
EP-1623704-A1 THERAPEUTIC AGENT TAKARA BIO INC. (JP) 2006-02-08 EP claimed
US-20070092551-A1 Therapeutic agent TAKARA BIO INC. (JP) 2007-04-26 US disclosed
US-20070092551-A1 Therapeutic agent TAKARA BIO INC. (JP) 2007-04-26 US disclosed
US-20070092551-A1 Therapeutic agent TAKARA BIO INC. (JP) 2007-04-26 US disclosed
EP-1623704-A1 THERAPEUTIC AGENT TAKARA BIO INC. (JP) 2006-02-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070092551-A1 Therapeutic agent FABP4, GPR119, IAPP PTPN1 1950/4885DHODH 3351/4885MAOB 4382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.